Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Permedica has a broad commercial portfolio of hip, knee, and shoulder arthroplasty products. Clinical follow-up data for custom solutions show excellent outcomes in mobility and implant integration at four months post-surgery[6].
The company’s TRASER® technology enables rapid development of patient-specific solutions with demonstrated clinical success.
No specific clinical trial results are published; products are CE-marked and widely adopted in Europe and globally.
Custom-made cases report stable integration and restoration of function within months post-operation[6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Permedica.